annual working capital:
$690.59M+$230.74M(+50.18%)Summary
- As of today (September 19, 2025), VRDN annual working capital is $690.59 million, with the most recent change of +$230.74 million (+50.18%) on December 31, 2024.
- During the last 3 years, VRDN annual working capital has risen by +$504.06 million (+270.23%).
- VRDN annual working capital is now at all-time high.
Performance
VRDN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$526.16M-$97.35M(-15.61%)Summary
- As of today (September 19, 2025), VRDN quarterly working capital is $526.16 million, with the most recent change of -$97.35 million (-15.61%) on June 30, 2025.
- Over the past year, VRDN quarterly working capital has dropped by -$18.74 million (-3.44%).
- VRDN quarterly working capital is now -27.52% below its all-time high of $725.99 million, reached on September 30, 2024.
Performance
VRDN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
VRDN Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +50.2% | -3.4% |
| 3 y3 years | +270.2% | +263.5% |
| 5 y5 years | +3430.8% | +1939.6% |
VRDN Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +270.2% | -27.5% | +263.5% |
| 5 y | 5-year | at high | +3430.8% | -27.5% | +2055.2% |
| alltime | all time | at high | +2835.4% | -27.5% | +2184.2% |
VRDN Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $526.16M(-15.6%) |
| Mar 2025 | - | $623.51M(-9.7%) |
| Dec 2024 | $690.59M(+50.2%) | $690.59M(-4.9%) |
| Sep 2024 | - | $725.99M(+33.2%) |
| Jun 2024 | - | $544.90M(-9.3%) |
| Mar 2024 | - | $600.69M(+30.6%) |
| Dec 2023 | $459.84M(+15.6%) | $459.84M(+53.0%) |
| Sep 2023 | - | $300.59M(-5.4%) |
| Jun 2023 | - | $317.67M(-10.0%) |
| Mar 2023 | - | $353.01M(-11.3%) |
| Dec 2022 | $397.82M(+113.3%) | $397.82M(+174.8%) |
| Jun 2022 | - | $144.76M(-12.3%) |
| Mar 2022 | - | $165.00M(-11.5%) |
| Dec 2021 | $186.53M(+56.8%) | $186.53M(-8.4%) |
| Sep 2021 | - | $203.60M(+106.4%) |
| Jun 2021 | - | $98.63M(-6.2%) |
| Mar 2021 | - | $105.10M(-11.6%) |
| Dec 2020 | $118.94M(+508.1%) | $118.94M(+387.2%) |
| Sep 2020 | - | $24.41M(-5.4%) |
| Jun 2020 | - | $25.80M(-13.1%) |
| Mar 2020 | - | $29.68M(+51.7%) |
| Dec 2019 | $19.56M | $19.56M(-29.7%) |
| Sep 2019 | - | $27.83M(-28.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $38.93M(-17.8%) |
| Mar 2019 | - | $47.35M(-19.3%) |
| Dec 2018 | $58.64M(+22.2%) | $58.64M(-14.9%) |
| Sep 2018 | - | $68.92M(-10.4%) |
| Jun 2018 | - | $76.94M(-6.4%) |
| Mar 2018 | - | $82.22M(+71.4%) |
| Dec 2017 | $47.97M(<-9900.0%) | $47.97M(+20.3%) |
| Sep 2017 | - | $39.89M(-6.6%) |
| Jun 2017 | - | $42.72M(-14.0%) |
| Mar 2017 | - | $49.66M(+192.3%) |
| Dec 2016 | -$326.00K(-103.5%) | $16.99M(+364.4%) |
| Sep 2016 | - | $3.66M(-31.8%) |
| Jun 2016 | - | $5.37M(-25.7%) |
| Mar 2016 | - | $7.23M(-22.0%) |
| Dec 2015 | $9.27M(+93.2%) | $9.27M(-19.4%) |
| Sep 2015 | - | $11.49M(+17.4%) |
| Jun 2015 | - | $9.78M(-18.4%) |
| Mar 2015 | - | $12.00M(+150.1%) |
| Dec 2014 | $4.80M(-119.0%) | $4.80M(-28.0%) |
| Sep 2014 | - | $6.66M(-12.7%) |
| Jun 2014 | - | $7.63M(-130.2%) |
| Dec 2013 | -$25.25M(+15.1%) | -$25.25M(+15.1%) |
| Dec 2012 | -$21.94M | - |
| Dec 2012 | - | -$21.94M |
FAQ
- What is Viridian Therapeutics, Inc. annual working capital?
- What is the all time high annual working capital for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual working capital year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly working capital?
- What is the all time high quarterly working capital for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly working capital year-on-year change?
What is Viridian Therapeutics, Inc. annual working capital?
The current annual working capital of VRDN is $690.59M
What is the all time high annual working capital for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual working capital is $690.59M
What is Viridian Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, VRDN annual working capital has changed by +$230.74M (+50.18%)
What is Viridian Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of VRDN is $526.16M
What is the all time high quarterly working capital for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly working capital is $725.99M
What is Viridian Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, VRDN quarterly working capital has changed by -$18.74M (-3.44%)